Compliance with Medicare and Medicaid Programs. AmeriPath and its Affiliates have timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and Federal Health Care Programs in which each participates due on or before the Effective Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect. Except as set forth in Schedule 3.8(c) hereto, there are no Claims pending or scheduled or to the knowledge of AmeriPath threatened before any Authority, including without limitation, any intermediary, carrier, the Administrator of the Centers for Medicare and Medicaid Services, the Agency for Health Care Administration or any other state or federal agency with respect to any Federal Health Care Program claim filed by AmeriPath or its Affiliates on or before the Effective Date, or program compliance matters, which would have a Material Adverse Effect. Except for routinely scheduled reviews pursuant to the Medicare and Medicaid Contracts of AmeriPath and its Affiliates, AmeriPath and its Affiliates have not received notice of any review or program integrity review related to such entity by any Authority in connection with the Medicare or Medicaid programs and no such review is, to their knowledge, pending or scheduled or threatened, against or affecting such entity, or its business, its assets, or the consummation of the transactions contemplated hereby.
Compliance with Medicare and Medicaid Programs. The Companies have timely and accurately filed all requisite claims and other reports required to be filed in
Compliance with Medicare and Medicaid Programs. Except as set forth in Schedule 4.16, the Facilities are qualified provider participants in the Medicaid program in the state in which they operate and providers in the Medicare program; and no Seller or Facility has been determined not to be in compliance in any material respect with the conditions for participation in the Medicare and Medicaid programs. Except as set forth in Schedule 4.16, the Sellers and/or the Facilities have timely filed all requisite cost reports required to be filed by them in connection with Medicare and Medicaid. Except for those reviews which are conducted by Regulatory Authorities in the Ordinary Course of Business and as set forth on Schedule 4.16, to the Sellers’ Knowledge, no validation review or program integrity review related to any Facility has been conducted by any commission, board or agency in connection with Medicare or Medicaid and no such reviews are pending against the Sellers, the Facilities or the consummation of this Agreement. To the Knowledge of Sellers, neither the Sellers nor any of their licensed Employees has been convicted of, or pled guilty or nolo contendere to any criminal offense related to any Medicare or Medicaid program while such person was an Employee of the Sellers or after the termination of such person’s employment by the Sellers for acts committed while employed by the Sellers, and, to the Knowledge of the Sellers, none of such employees has committed any offense related to any Medicare or Medicaid program for acts committed while employed by the Sellers which may serve as the basis for suspension, restriction, or exclusion of the Sellers from the Medicare and Medicaid programs. Except as set forth on Schedule 4.16, no Seller has received written notice of any proceeding, or to the Knowledge of Sellers, do they believe that any proceeding is recommended or threatened by the appropriate Regulatory Authority having jurisdiction thereof, to revoke, limit, suspend or take any adverse action against such Seller’s participation in Medicare and Medicaid programs, nor have the Sellers received written notice of any decision not to renew any provider agreement related to any Facility or any action of any other type which would have a Material Adverse Effect.
Compliance with Medicare and Medicaid Programs. Seller has timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and federal Medicare and Medicaid programs in which Seller participates due on or before the Closing Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect on Seller. Except as set forth on SCHEDULE 2.31(c) hereto, there are no Claims pending or, to Seller's knowledge, threatened or scheduled before any Authority, including without limitation, any intermediary, carrier, the Administrator of the Health Care Financing Administration, the Indiana Department of Health and Rehabilitative Services, the Agency for Health Care Administration or any other state or federal agency with respect to any Medicare and Medicaid claim filed by Seller on or before the Closing Date, or program compliance matters, which would have a Material Adverse Effect on Seller, or its assets, the operations or utility thereof, or the consummation of the transactions contemplated hereby. Seller has delivered to the Purchaser accurate and complete copies of any Claims, actions or appeals listed on SCHEDULE 2.31
Compliance with Medicare and Medicaid Programs. Each Unipath Entity has timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and federal Medicare and Medicaid programs in which any Unipath Entity participates due on or before the Closing Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect to any Unipath Entity. Except as set forth on Schedule 2.29(c) hereto, there are no Claims pending or, to any Seller's knowledge, threatened or scheduled before any Authority, including without limitation, any intermediary, carrier, the Administrator of the Health Care Financing Administration, the Texas Department of Health and Rehabilitative Services, the Agency for Healthcare Administration or any other state or federal agency with respect to any Medicare and Medicaid claim filed by any Unipath Entity on or before the Closing Date, or program compliance matters, which would have a Material Adverse Effect on any Unipath Entity, or its assets, the operations or utility thereof, or the consummation of the transactions contemplated hereby. Each Unipath Entity has delivered to the Purchaser accurate and complete copies of any Claims, actions or appeals listed on Schedule 2.29(c). Except for routinely scheduled reviews pursuant to each Unipath Entity's Medicare and Medicaid Contracts, no valid review or program integrity review related to the Unipath Entities has been conducted by any Authority in connection with the Medicare or Medicaid programs and no such review is scheduled, or to any Seller's knowledge, pending or threatened against or affecting any Unipath Entity, its business, assets, or the consummation of the transactions contemplated hereby.
Compliance with Medicare and Medicaid Programs. The Practice has timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and Federal Health Care Programs in which the Practice participates due on or before the Effective Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect. Except as set forth in Schedule 2.30(c) hereto, there are no Claims pending or scheduled or to the knowledge of Sellers or the Practice threatened before any Authority, including without limitation, any intermediary, carrier, the Administrator of the Centers for Medicare and Medicaid Services, the Agency for Health Care Administration or any other state or federal agency with respect to any Federal Health Care Program claim filed by the Practice on or before the Effective Date, or program compliance matters, which would have a Material Adverse Effect. The Practice has delivered to AmeriPath accurate and complete copies of any Claims, actions or appeals listed in Schedule 2.30(c). Except for routinely scheduled reviews pursuant to the Medicare and Medicaid Contracts of the Practice, the Practice and Sellers have not received notice of any review or program integrity review related to the Practice by any Authority in connection with the Medicare or Medicaid programs and no such review is, to the knowledge of the Practice and Sellers, pending or scheduled or threatened, against or affecting the Practice, or its business, its assets, or the consummation of the transactions contemplated hereby.
Compliance with Medicare and Medicaid Programs. Gulf Coast has timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and federal Medicare and Medicaid programs in which Gulf Coast participates due on or before the Closing Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect on Gulf
Compliance with Medicare and Medicaid Programs. To the best of the Sellers' actual knowledge, SLA has timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and federal Medicare and Medicaid programs in which SLA participates due on or before the Closing Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect on SLA. Except as set forth on Schedule 2.30(c) hereto, there are no Claims pending or, to SLA's knowledge, threatened or scheduled before any Authority, including without limitation, any intermediary, carrier, the Administrator of the Health Care Financing Administration, the Florida Department of Health and Rehabilitative Services, the Agency for Health Care Administration or any other state or federal agency with respect to any Medicare and Medicaid claim filed by SLA on or before the Closing Date, or program compliance matters, which would have a Material Adverse Effect on SLA, or its assets, the operations or utility thereof, or the consummation of the transactions contemplated hereby. SLA has delivered to the Purchaser accurate and 41 complete copies of any Claims, actions or appeals listed on Schedule 2.30(c). Except for routinely scheduled reviews pursuant to SLA's Medicare and Medicaid Contracts, no valid review or program integrity review related to SLA has been conducted by any Authority in connection with the Medicare or Medicaid programs and no such review is scheduled, or to SLA's knowledge, pending or threatened against or affecting SLA, its business, assets, or the consummation of the transactions contemplated hereby.
Compliance with Medicare and Medicaid Programs. CP&I has timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and federal Medicare and Medicaid programs in which CP&I participates due on or before the Closing Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect on CP&I. Except as set forth on Schedule 2.30(c) hereto, there are no Claims pending or, to CP&I's knowledge, threatened or scheduled before any Authority, including without limitation, any intermediary, carrier, the Administrator of the Health Care Financing Administration, the Department of Health and Rehabilitative Services, the Agency for Health Care Administration or any other state or federal agency with respect to any Medicare and Medicaid claim filed by CP&I on or before the Closing Date, or program compliance matters, which would have a Material Adverse Effect on CP&I, or its assets, the operations or utility thereof, or the consummation of the transactions contemplated hereby. CP&I has delivered to the Purchaser accurate and complete copies of any Claims, actions or appeals listed on Schedule 2.30
Compliance with Medicare and Medicaid Programs. The Practice has timely and accurately filed all requisite claims and other reports required to be filed in connection with all state and Federal Health Care Programs in which the Practice participates due on or before the Closing Date except to the extent that the failure to file such claims and reports would not result in a Material Adverse Effect. Except as set forth on Schedule 2.30(c) hereto, there are no Claims pending or scheduled or threatened before any Authority, including without limitation, any intermediary, carrier, the Administrator of the Health Care Financing Administration, the Agency for Health Care Administration or any other state or federal agency with respect to any Federal Health Care Program claim filed by the Practice on or before the Closing Date, or program compliance matters, which would have a Material Adverse Effect. The Practice has delivered to AmeriPath accurate and complete copies of any Claims, actions or appeals listed on Schedule 2.30(c). Except for routinely scheduled reviews pursuant to the Medicare and Medicaid Contracts of the Practice, no review or program integrity review related to the Practice has been conducted by any Authority in connection with the Medicare or Medicaid programs and no such review is pending or scheduled or threatened, against or affecting the Practice, or its business, its assets, or the consummation of the transactions contemplated hereby.
